The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one ID: ALA5208588
PubChem CID: 168295240
Max Phase: Preclinical
Molecular Formula: C15H11F3N6O3S
Molecular Weight: 412.35
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nnc2n1CCN(c1nc(=O)c3cc(C(F)(F)F)cc([N+](=O)[O-])c3s1)C2
Standard InChI: InChI=1S/C15H11F3N6O3S/c1-7-20-21-11-6-22(2-3-23(7)11)14-19-13(25)9-4-8(15(16,17)18)5-10(24(26)27)12(9)28-14/h4-5H,2-3,6H2,1H3
Standard InChI Key: CVUPJRFXCUZFKX-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
1.7851 1.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0695 0.9934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0695 0.1723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7831 -0.2336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4914 0.1771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4914 0.9939 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3623 -0.2361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3501 0.1758 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.0559 -0.2380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0559 -1.0594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3480 -1.4668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3623 -1.0575 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3480 -2.2836 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7658 -1.4659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4747 -1.0594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4747 -0.2380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7658 0.1767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7658 0.9935 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4732 1.4020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0584 1.4020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1814 -1.4688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1801 -2.2858 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.8890 -1.0603 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.8890 -1.8773 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.0998 1.5388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9569 2.2026 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7695 2.2858 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8890 1.3273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
3 4 1 0
5 4 1 0
1 6 1 0
6 5 1 0
3 7 1 0
8 7 1 0
8 9 1 0
10 9 2 0
11 10 1 0
7 12 2 0
12 11 1 0
11 13 2 0
14 10 1 0
15 14 2 0
16 15 1 0
17 16 2 0
17 9 1 0
18 17 1 0
18 19 2 0
18 20 1 0
21 15 1 0
21 22 1 0
21 23 1 0
21 24 1 0
6 25 1 0
1 26 2 0
26 27 1 0
27 25 2 0
25 28 1 0
M CHG 2 18 1 20 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 412.35Molecular Weight (Monoisotopic): 412.0565AlogP: 2.50#Rotatable Bonds: 2Polar Surface Area: 107.05Molecular Species: NEUTRALHBA: 9HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.32CX LogP: 1.46CX LogD: 1.46Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.47Np Likeness Score: -1.93
References 1. Schieferdecker S, Bernal FA, Wojtas KP, Keiff F, Li Y, Dahse HM, Kloss F.. (2022) Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones., 65 (9.0): [PMID:35502994 ] [10.1021/acs.jmedchem.2c00098 ]